Obesity and COVID-19: Oro-Naso-Sensory Perception
Abstract
:1. Introduction
2. Obesity and Reduced Viral Protection
3. COVID-19 and Reduced Oro-Naso-Sensory (ONS) Perception
4. Obesity and Reduced ONS Perception
5. Conclusions
6. Perspectives
Author Contributions
Funding
Conflicts of Interest
References
- Zhou, F.; Yu, T.; Du, R.; Fan, G.; Liu, Y.; Liu, Z.; Xiang, J.; Wang, Y.; Song, B.; Gu, X.; et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 2020, 395, 1054–1062. [Google Scholar] [CrossRef]
- Hui, D.S.; Azhar, E.I.; Madani, T.A.; Ntoumi, F.; Kock, R.; Dar, O.; Ippolito, G.; Mchugh, T.D.; Memish, Z.A.; Drosten, C.; et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan, China. Int. J. Infect. Dis. 2020, 91, 264–266. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Richardson, R.; Hirsch, J.S.; Narasimhan, M.; Crawford, J.M.; McGinn, T.; Davidson, K.W. Presenting Characteristics, Comorbidities, and Outcomes among 5700 Patients Hospitalized with COVID-19 in the New York City Area. Jama 2020, 323, 2052–2059. [Google Scholar] [CrossRef] [PubMed]
- Hruby, A.; Hu, F.B. The Epidemiology of Obesity: A Big Picture. Pharmacoeconomics 2015, 33, 673–689. [Google Scholar] [CrossRef]
- Van Kerkhove, M.D.; Vandemaele, K.A.; Shinde, V.; Jaramillo-Gutierrez, G.; Koukounari, A.; Donnelly, C.A.; Carlino, L.O.; Owen, R.; Paterson, B.; Pelletier, L.; et al. Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: A global pooled analysis. PLoS Med. 2011, 8, e100. [Google Scholar] [CrossRef] [Green Version]
- Salvator, H.; Grassin-Delyle, S.; Naline, E.; Brollo, M.; Fournier, C.; Couderc, L.J.; Devillier, P. Contrasting effects of adipokines on the cytokine production by primary human bronchial epithelial cells: Inhibitory effects of adiponectin. Front. Pharmacol. 2020, 11, 56. [Google Scholar] [CrossRef] [Green Version]
- Zhou, Y.; Cowling, B.J.; Wu, P.; Chan, W.M.; Lee, S.Y.; Lau, E.H.; Schooling, C.M. Adiposity and influenza-associated respiratory mortality: A cohort study. Clin. Infect. Dis. 2015, 60, e49–e57. [Google Scholar] [CrossRef] [Green Version]
- Vaillant, L.; La Ruche, G.; Tarantola, A.; Barboza, P. Epidemic intelligence team at In VS Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Eurosurveillance 2009, 14, 19309. [Google Scholar] [CrossRef]
- Gill, J.R.; Sheng, Z.M.; Ely, S.F.; Guinee, D.G., Jr.; Beasley, M.B.; Suh, J.; Deshpande, C.; Mollura, D.J.; Morens, D.M.; Bray, M.; et al. Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch. Pathol. Lab. Med. 2010, 134, 235–243. [Google Scholar] [CrossRef]
- Taubenberger, J.K.; Morens, D.M. The pathology of influenza virus infections. Annu. Rev. Pathol. 2008, 3, 499–522. [Google Scholar] [CrossRef]
- Honce, R.; Schultz-Cherry, S. Impact of obesity on influenza a virus pathogenesis, immune response, and evolution. Front. Immunol. 2019, 10, 1071. [Google Scholar] [CrossRef] [PubMed]
- Falagas, M.E.; Kompoti, M. Obesity and infection. Lancet Infect. Dis. 2006, 6, 438–446. [Google Scholar] [CrossRef]
- Simonnet, A.; Chetboun, M.; Poissy, J.; Raverdy, V.; Noulette, J.; Duhamel, A.; Labreuche, J.; Mathieu, D.; Pattou, F.; Jourdain, M. High Prevalence of Obesity in Severe Acute Respiratory Syndrome coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation. Obesity 2020. [Google Scholar] [CrossRef] [PubMed]
- Khan, N.A. Inflammation & Immunity: Implications in obesity and type-2 diabetes. Oilseeds Fats Crop. Lipids 2006, 13, 343–351. [Google Scholar] [CrossRef]
- Huttunen, R.; Syrjanen, J. Obesity and the outcome of infection. Lancet Infect. Dis. 2010, 10, 442–443. [Google Scholar] [CrossRef]
- Nave, H.; Beutel, G.; Kielstein, J.T. Obesity-related immunodeficiency in patients with pandemic influenza H1N1. Lancet Infect. Dis. 2011, 11, 14–15. [Google Scholar] [CrossRef]
- Sheridan, P.A.; Paich, H.A.; Handy, J.; Karlsson, E.A.; Hudgens, M.G.; Sammon, A.B.; Holland, L.A.; Weir, S.; Noah, T.L.; Beck, M.A. Obesity is associated with impaired immune response to influenza vaccination in humans. Int. J. Obes. 2011, 36, 1072–1077. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tan, M.; Liu, Y.; Zhou, R.; Deng, X.; Li, F.; Liang, K.; Shi, Y. Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China. Immunology 2020. [Google Scholar] [CrossRef]
- Klagge, I.M.; Schneider-Schaulies, S. Virus interactions with dendritic cells. J. Gen. Virol. 1999, 80, 823–833. [Google Scholar] [CrossRef]
- O’Shea, D.; Corrigan, M.; Dunne, M.R.; Jackson, R.; Woods, C.; Gaoatswe, G.; Moynagh, P.N.; O’Connell, J.; Hogan, A.E. Changes in human dendritic cell number and function in severe obesity may contribute to increased susceptibility to viral infection. Int. J. Obes. 2013, 37, 1510–1513. [Google Scholar] [CrossRef] [Green Version]
- Mittal, S.K.; Cho, K.-I.; Ishido, S.; Roche, P.A. Interleukin 10 (IL-10)-mediated Immunosuppression march-i induction regulates antigen presentation by macrophages but not dendritic cells. J. Biol. Chem. 2015, 290, 27158–27167. [Google Scholar] [CrossRef] [Green Version]
- Mattioli, B.; Straface, E.; Quaranta, M.G.; Giordani, L.; Viora, M. Leptin promotes differentiation and survival of human dendritic cells and licenses them for Th1 priming. J. Immunol. 2005, 174, 6820–6828. [Google Scholar] [CrossRef] [PubMed]
- Kern, P.A.; Saghizadeh, M.; Ong, J.M.; Bosch, R.J.; Deem, R.; Simsolo, R.B. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J. Clin. Investig. 1995, 95, 2111–2119. [Google Scholar] [CrossRef] [Green Version]
- Dandona, P.; Aljada, A.; Bandyopadhyay, A. Inflammation: The link between insulin resistance, obesity and diabetes. Trends Immunol. 2004, 25, 4–7. [Google Scholar] [CrossRef]
- Chanput, W.; Mes, J.; Vreeburg, R.A.M.; Savelkoul, H.F.J.; Wichers, H.J. Transcription profiles of LPS-stimulated THP-1 monocytes and macrophages: A tool to study inflammation modulating effects of food-derived compounds. Food Funct. 2010, 1, 254–261. [Google Scholar] [CrossRef]
- Biobaku, F.; Ghanim, H.; Batra, M.; Dandona, P. Macronutrient-Mediated Inflammation and Oxidative Stress: Relevance to Insulin Resistance, Obesity, and Atherogenesis. J. Clin. Endocrinol. Metab. 2019, 104, 6118–6128. [Google Scholar] [CrossRef] [PubMed]
- Kanterman, J.; Sade-Feldman, M.; Baniyash, M. New Insights into Chronic Inflammation-Induced Immunosuppression. Semin. Cancer Biol. 2012, 22, 307–318. [Google Scholar] [CrossRef]
- Milner, J.J.; Beck, M.A. The impact of obesity on the immune response to infection. Proc. Nutr. Soc. 2012, 71, 298–306. [Google Scholar] [CrossRef] [Green Version]
- Luzi, L.; Radaelli, M.G. Influenza and obesity: Its odd relationship and the lessons for COVID-19 pandemic. Acta Diabetol. 2020, 57, 759–764. [Google Scholar] [CrossRef] [Green Version]
- Bello-Chavolla, O.Y.; Bahena-López, J.P.; Antonio-Villa, N.E.; Vargas-Vázquez, A.; González-Díaz, A.; Márquez-Salinas, A.; Fermín-Martínez, C.A.; Naveja, J.J.; Aguilar-Salinas, C.A. Predicting mortality due to SARS-CoV-2: A mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico. J. Clin. Endocrinol. Metab. 2020. [Google Scholar] [CrossRef] [PubMed]
- Berbudi, A.; Rahmadika, N.; Cahyadi, A.I.; Ruslami, R. Type 2 diabetes and its impact on the immune system. Curr. Diabetes Rev. 2019. [Google Scholar] [CrossRef]
- Bornstein, S.R.; Dalan, R.; Hopkins, D.; Mingrone, G.; Boehm, B.O. Endocrine and metabolic link to coronavirus infection. Nat. Rev. Endocrinol. 2020, 16, 297–298. [Google Scholar] [CrossRef] [Green Version]
- Cariou, B.; Hadjadj, S.; Wargny, M.; Pichelin, M.; Al-Salameh, A.; Allix, I.; Amadou, C.; Arnault, G.; Baudoux, F.; Bauduceau, B.; et al. Phenotypic characteristics and prognosis of in-patients with COVID-19 and diabetes: The CORONADO study. Diabetologia 2020. [Google Scholar] [CrossRef]
- Scheen, A.J.; Marre, M.; Thivolet, C. Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports. Diabetes Metab. 2020, in press, corrected proof. [Google Scholar] [CrossRef] [PubMed]
- Petrakis, D.; Margină, D.; Tsarouhas, K.; Tekos, F.; Stan, M.; Nikitovic, D.; Kouretas, D.; Spandidos, D.A.; Tsatsakis, A. Obesity—A risk factor for increased COVID-19 prevalence, severity and lethality (Review). Mol. Med. Rep. 2020, 2, 9–19. [Google Scholar] [CrossRef]
- Aggarwal, S.; Garcia-Telles, N.; Aggarwal, G.; Lavie, C.; Lippi, G.; Henry, B.M. Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): Early report from the United States. Diagnosis 2020, 7, 91–96. [Google Scholar] [CrossRef]
- Xydakis, M.S.; Dehgani-Mobaraki, P.; Holbrook, E.H.; Geisthoff, U.W.; Bauer, C.; Hautefort, C.; Herman, P.; Manley, G.T.; Lyon, D.M.; Hopkins, C. Smell and taste dysfunction in patients with COVID-19. Lancet Infect. Dis. 2020. [Google Scholar] [CrossRef]
- Emami, A.; Javanmardi, F.; Pirbonyeh, N.; Akbari, A. Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis. Arch. Acad. Emerg. Med. 2020, 24, e35. [Google Scholar]
- Lechien, J.R.; Chiesa-Estomba, C.M.; De Siati, D.R.; Horoi, M.; Le Bon, S.D.; Rodriguez, A.; Dequanter, D.; Blecic, S.; El Afia, F.; Distinguin, L.; et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): A multicenter European study. Eur. Arch. Otorhinolaryngol. 2020, 6, 1–11. [Google Scholar] [CrossRef]
- Tong, J.Y.; Wong, A.; Zhu, D.; Fastenberg, J.H.; Tham, T. The prevalence of olfactory and gustatory dysfunction in COVID-19 patients: A systematic review and meta-analysis. Otolaryngol.-Head Neck Surg. 2020. [Google Scholar] [CrossRef]
- Gautierr, J.F.; Ravussin, Y. A New Symptom of COVID-19: Loss of Taste and Smell. Obesity 2020, 28, 848. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Stone, J. There’s an Unexpected Loss of Smell and Taste in Coronavirus Patients. Forbes, 20 March 2020. [Google Scholar]
- Coelho, D.H.; Kons, Z.A.; Costanzo, R.M.; Reiter, E.R. Subjective Changes in Smell and Taste during the COVID-19 Pandemic: A National Survey-Preliminary Results. Otolaryngol.-Head Neck Surg. 2020, 19. [Google Scholar] [CrossRef] [PubMed]
- Paderno, A.; Schreiber, A.; Grammatica, A.; Raffetti, E.; Tomasoni, M.; Gualtieri, T.; Taboni, S.; Zorzi, S.; Lombardi, D.; Deganello, A.; et al. Smell and taste alterations in Covid-19: A cross-sectional analysis of different cohorts. Int. Forum Allergy Rhinol. 2020. [CrossRef] [PubMed]
- Mao, L.; Wang, M.; Chen, S.; He, Q.; Chang, J.; Hong, C.; Zhou, Y.; Wang, D.; Miao, X.; Hu, Y.; et al. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: A retrospective case series study. SSRN 2020. [Google Scholar] [CrossRef]
- Li, Y.; Bai, W.; Hashikawa, T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J. Med. Virol. 2020. [Google Scholar] [CrossRef]
- Mao, L.; Jin, H.; Wang, M.; Hu, Y.; Chen, S.; He, Q.; Chang, J.; Hong, C.; Zhou, Y.; Wang, D.; et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020, 77, 683–690. [Google Scholar] [CrossRef] [Green Version]
- Li, K.; Wohlford-Lenane, C.; Perlman, S.; Zhao, J.; Jewell, A.K.; Reznikov, L.R.; Gibson-Corley, K.N.; Meyerholz, D.K.; McCray, P.B., Jr. Middle east respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4. J. Infect. Dis. 2016, 213, 712–722. [Google Scholar] [CrossRef] [Green Version]
- Bilinska, K.; Jakubowska, P.; Von Bartheld, C.S.; Butowt, R. Expression of the SARS-CoV-2 Entry Proteins, ACE2 and TMPRSS2, in Cells of the Olfactory Epithelium: Identification of Cell Types and Trends with Age. ACS Chem. Neurosci. 2020, 11, 1555–1562. [Google Scholar] [CrossRef]
- Yee, K.K.; Pribitkin, E.A.; Cowart, B.J.; Rosen, D.; Feng, P.; Rawson, N.E. Analysis of the olfactory mucosa in chronic rhinosinusitis. Ann. N. Y. Acad. Sci. 2009, 1170, 590–595. [Google Scholar] [CrossRef] [Green Version]
- Tian, J.; Pinto, J.M.; Cui, X.; Zhang, H.; Li, L.; Liu, Y.; Wu, C.; Wei, Y. Sendai virus induces persistent olfactory dysfunction in a murine model of PVOD via effects on apoptosis, cell proliferation, and response to odorants. PLoS ONE 2016, 11, e0159033. [Google Scholar] [CrossRef]
- Lane, A.P.; Zhao, H.; Reed, R.R. Development of transgenic mouse models for the study of human olfactory dysfunction. Am. J. Rhinol. 2005, 19, 229–235. [Google Scholar] [CrossRef]
- Getchell, T.V.; Subhedar, N.K.; Shah, D.S.; Hackely, G.; Partin, J.V.; Sen, G.; Getchell, M.L. Chemokine regulation of macrophage recruitment into the olfactory epithelium following target ablation: Involvement of macrophage inflammatory proterin-alpha and monocyte chemoattractant protein-1. J. Neurosci. Res. 2002, 70, 784–793. [Google Scholar] [CrossRef] [PubMed]
- Xu, H.; Hao, X.; Liang, Z.; Jiaxin, D.; Jiakuan, P.; Hongxia, D.; Xin, Z.; Taiwen, L.; Qianming, C. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int. J. Oral. Sci. 2020, 12, 8. [Google Scholar] [CrossRef] [PubMed]
- Hong, W.M.Z.; Brand, J.; Huang, L. Inflammation and taste disorders: Mechanisms in taste buds. Ann. N. Y. Acad. Sci. 2009, 1170, 596–603. [Google Scholar]
- Gomez, F.E.; Cassis-Nosthas, L.; Morales-de-Leon, J.C.; Bourges, H. Detection and recognition thresholds to the 4 basic tastes in Mexican patients with primary Sjögren’s syndrome. Eur. J. Clin. Nutr. 2004, 58, 629–636. [Google Scholar] [CrossRef] [Green Version]
- Campbell, S.M.; Montanaro, A.; Bardana, E.J. Head and neck manifestations of autoimmune disease. Am. J. Otolaryngol. 1983, 4, 187–216. [Google Scholar] [CrossRef]
- Šakić, B.; Szechtman, H.; Braciak, T.; Richards, C.; Gauldie, J.; Denburg, J.A. Reduced preference for sucrose in autoimmune mice: A possible role of interleukin-6. Brain Res. Bull. 1997, 44, 155–165. [Google Scholar] [CrossRef]
- Wang, H.; Zhou, M.; Brand, J.; Huang, L. Inflammation activates the interferon signaling pathways in taste bud cells. J. Neurosci. 2007, 27, 10703–10713. [Google Scholar] [CrossRef]
- Chigr, F.; Merzouki, M.; Najimi, M. Autonomic Brain Centers and Pathophysiology of COVID-19. ACS Chem. Neurosci. 2020. [Google Scholar] [CrossRef]
- Chigr, F.; Merzouki, M.; Najimi, M. Comment on “The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients”. J. Med. Virol. 2020. [Google Scholar] [CrossRef] [PubMed]
- Ralli, M.; Di Stadio, A.; Greco, A.; de Vincentiis, M.; Polimeni, A. Defining the burden of olfactory dysfunction in COVID-19 patients. Eur. Rev. Med. Pharmacol. Sci. 2020, 24, 3440–3441. [Google Scholar] [PubMed]
- Acharya, A.; Kevadiya, B.D.; Gendelman, H.E.; Byrareddy, S.N. SARS-CoV-2 Infection Leads to Neurological Dysfunction. J. Neuroimmune Pharmacol. 2020, 15, 167–173. [Google Scholar] [CrossRef] [PubMed]
- Netland, J.; Meyerholz, D.K.; Moore, S.; Cassell, M.; Perlman, S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J. Virol. 2008, 82, 7264–7275. [Google Scholar] [CrossRef] [Green Version]
- Eliezer, M.; Hautefort, C.; Hamel, A.L.; Verillaud, B.; Herman, P.; Houdart, E.; Eloit, C. Sudden and complete olfactory loss function as a possible symptom of COVID-19. JAMA Otolaryngol.-Head Neck Surg. 2020. [Google Scholar] [CrossRef] [Green Version]
- Hamming, I.; Timens, W.; Bulthuis, M.L.; Lely, A.T.; Navis, G.; van Goor, H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus: A first step in understanding SARS pathogenesis. J. Pathol. 2004, 203, 631–637. [Google Scholar] [CrossRef] [PubMed]
- Bartoshuk, L.M.; Duffy, V.B.; Hayes, J.E.; Moskowitz, H.R.; Snyder, D.J. Psychophysics of sweet and fat perception in obesity: Problems, solutions and new perspectives. Philos Trans. R Soc. Lond B Biol. Sci. 2006, 361, 1137–1148. [Google Scholar] [CrossRef] [Green Version]
- Deglaire, A.; Mejean, C.; Castetbon, K.; Kesse-Guyot, E.; Hercberg, S.; Schlich, P. Associations between weight status and liking scores for sweet, salt and fat according to the gender in adults (The Nutrinet-Sante study). Eur. J. Clin. Nutr. 2015, 69, 40–46. [Google Scholar] [CrossRef]
- Volkow, N.D.; Wang, G.J.; Tomasi, D.; Baler, R.D. Obesity and addiction: Neurobiological overlaps. Obes. Rev. 2013, 14, 2–18. [Google Scholar] [CrossRef] [Green Version]
- Sarkar, S.; Kochhar, K.P.; Khan, N.A. Fat Addiction: Psychological and Physiological Trajectory. Nutrients 2019, 15, 2785. [Google Scholar] [CrossRef] [Green Version]
- Bertoli, S.; Laureati, M.; Battezzati, A.; Bergamaschi, V.; Cereda, E.; Spadafranca, A.; Vignati, L.; Pagliarini, E. Taste sensitivity, nutritional status and metabolic syndrome: Implication in weight loss dietary interventions. World J. Diabetes 2014, 5, 717–723. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Maliphol, A.B.; Garth, D.J.; Medler, K.F. Diet-induced obesity reduces the responsiveness of the peripheral taste receptor cells. PLoS ONE 2013, 8, e79403. [Google Scholar] [CrossRef] [Green Version]
- Sartor, F.; Donaldson, L.F.; Markland, D.A.; Loveday, H.; Jackson, M.J.; Kubis, H.P. Taste perception and implicit attitude toward sweet related to body mass index and soft drink supplementation. Appetite 2011, 57, 237–246. [Google Scholar] [CrossRef]
- Besnard, P.; Passilly-Degrace, P.; Khan, N.A. Taste of Fat: A Sixth Taste Modality? Physiol. Rev. 2016, 96, 151–176. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Khan, A.S.; Keast, R.; Khan, N.A. Preference for dietary fat: From detection to disease. Prog. Lipid Res. 2020, 78, 101032. [Google Scholar] [CrossRef] [PubMed]
- Ozdener, M.H.; Subramaniam, S.; Sundaresan, S.; Sery, O.; Hashimoto, T.; Asakawa, Y.; Besnard, P.; Abumrad, N.A.; Khan, N.A. CD36- and GPR120-Mediated Ca2+ Signaling in Human Taste Bud Cells Mediates Differential Responses to Fatty Acids and Is Altered in Obese Mice. Gastroenterology 2014, 146, 995–1005. [Google Scholar] [CrossRef] [Green Version]
- Eny, K.M.; Wolever, T.M.; Corey, P.N.; El-Sohemy, A. Genetic variation in TAS1R2 (Ile191Val) is associated with consumption of sugars in overweight and obese individuals in 2 distinct populations. Am. J. Clin. Nutr. 2010, 92, 1501–1510. [Google Scholar] [CrossRef] [Green Version]
- Pioltine, M.B.; de Melo, M.E.; Santos, A.S.; Machado, A.D.; Fernandes, A.E.; Fujiwara, C.T.; Cercato, C.; Mancini, M.C. Genetic variation in CD36 is associated with decreased fat and sugar intake in obese childrenand adolescents. J. Nutrigenet. Nutrigenom. 2016, 9, 300–305. [Google Scholar] [CrossRef]
- Khan, A.S.; Hichami, A.; Khan, N.A. Taste perception and its effects on oral nutritional supplements in younger life phases. Curr. Opin. Clin. Nutr. Metab. Care 2018, 21, 411–415. [Google Scholar] [CrossRef]
- Loper, H.B.; La Sala, M.; Dotson, C.; Steinle, N. Taste perception, associated hormonal modulation, and nutrient intake. Nutr. Rev. 2015, 73, 83–91. [Google Scholar] [CrossRef] [Green Version]
- Kindleysides, S.; Beck, K.L.; Walsh, D.C.I.; Henderson, L.; Jayasinghe, S.N.; Golding, M.; Breier, B.H. Fat Sensation: Fatty Acid Taste and Olfaction Sensitivity and the Link with Disinhibited Eating Behaviour. Nutrients 2017, 9, 879. [Google Scholar] [CrossRef] [Green Version]
- Tomassini, B.I.; Ozdener, M.H.; Melis, M.; Love-Gregory, L.; Mitreva, M.; Abumrad, N.A.; Pepina, M.Y. Variant in a common odorant-binding protein gene is associated with bitter sensitivity in people. Behav. Brain Res. 2017, 329, 200–204. [Google Scholar] [CrossRef]
- Skrandies, W.; Zschieschang, R. Olfactory and gustatory functions and its relation to body weight. Physiol. Behav. 2015, 142, 1–4. [Google Scholar] [CrossRef] [PubMed]
- Patel, Z.M.; DelGaudio, J.M.; Wise, S.K. Higher body mass index is associated with subjective olfactory dysfunction. Behav. Neurol. 2015, 2015, 675635. [Google Scholar] [CrossRef] [Green Version]
- Pastor, A.; Fernández-Aranda, F.; Fitó, M.; Jiménez-Murcia, S.; Botella, C.; Fernández-Real, J.M.; Frühbeck, G.; Tinahones, F.J.; Fagundo, A.B.; Rodriguez, J.; et al. A lower olfactory capacity is related to higher circulating concentrations of endocannabinoid 2-arachidonoylglycerol and higher body mass index in women. PLoS ONE 2016, 11, e0148734. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jarick, I.; Vogel, C.I.; Scherag, S.; Schäfer, H.; Hebebrand, J.; Hinney, A.; Scherag, A. Novel common copy number variation for early onset extreme obesity on chromosome 11q11 identified by a genome-wide analysis. Hum. Mol. Genet. 2011, 20, 840–852. [Google Scholar] [CrossRef] [Green Version]
- Mariman, E.C.; Szklarczyk, R.; Bouwman, F.G.; Aller, E.E.; van Baak, M.A.; Wang, P. Olfactory receptor genes cooperate with protocadherin genes in human extreme obesity. Genes Nutr. 2015, 10, 465. [Google Scholar] [CrossRef] [Green Version]
- Ramos-Lopez, O.; Riezu-Boj, J.I.; Milagro, F.I.; Zulet, M.A.; Santos, J.L.; Martinez, J.A. Associations between olfactory pathway gene methylation marks, obesity features and dietary intakes. Genes Nutr. 2019, 14, 11. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gottfried, J.A. Central mechanisms of odour object perception. Nat. Rev. Neurosci. 2010, 11, 628–641. [Google Scholar] [CrossRef] [PubMed]
- Feng, P.; Chai, J.; Zhou, M.; Simon, N.; Huang, L.; Wang, H. Interleukin-10 is produced by a specific subset of taste receptor cells and critical for maintaining structural integrity of mouse taste buds. J. Neurosci. 2004, 34, 2689–2701. [Google Scholar] [CrossRef] [Green Version]
- Kaufman, A.; Choo, E.; Koh, A.; Dando, R. Inflammation arising from obesity reduces taste bud abundance and inhibits renewal. PLoS Biol. 2018, 16, e2001959. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cohn, Z.J.; Kim, A.; Huang, L.; Brand, J.; Wang, H. Lipopolysaccharide-induced inflammation attenuates taste progenitor cell proliferation and shortens the life span of taste bud cells. BMC Neurosci. 2010, 11, 72. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Thiebaud, N.; Johnson, M.C.; Butler, J.L.; Bell, G.A.; Ferguson, K.L.; Fadool, A.R.; Fadool, J.C.; Gale, A.M.; Gale, D.S.; Fadool, D.A. Hyperlipidemic diet causes loss of olfactory sensory neurons, reduces olfactory discrimi-nation, and disrupts odor-reversal learning. J. Neurosci. 2014, 34, 6970–6984. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Suzuki, Y.; Farbman, A.I. Tumor necrosis factor-alpha-induced apoptosis in olfactory epithelium in vitro: Possible roles of caspase 1 (ICE), caspase 2 (ICH-1), and caspase 3 (CPP32). Exp. Neurol. 2000, 165, 35–45. [Google Scholar] [CrossRef]
- Henkin, R.I.; Schmidt, L.; Velicu, I. Interleukin 6 in Hyposmia. JAMA Otolaryngol.-Head Neck Surg. 2013, 139, 728–734. [Google Scholar] [CrossRef] [Green Version]
- Small, D.M.; Voss, J.; Mak, Y.E.; Simmons, K.B.; Parrish, T.; Gitelman, D. Experience-dependent neural integration of taste and smell in the human brain. J. Neurophysiol. 2004, 92, 1892–1903. [Google Scholar] [CrossRef]
- Kang, N.; Koo, J. Olfactory receptors in non-chemosensory tissues. BMB Rep. 2012, 45, 612–622. [Google Scholar] [CrossRef] [Green Version]
- Palouzier-Paulignan, B.; Lacroix, M.C.; Aimé, P.; Baly, C.; Caillol, M.; Congar, P.; Julliard, A.K.; Tucker, K.; Fadool, D.A. Olfaction Under Metabolic Influences. Chemical. Senses 2012, 37, 769–797. [Google Scholar] [CrossRef]
- Zuo, T.; Zhang, F.; Lui, G.C.; Yeoh, Y.K.; Li, A.Y.; Zhan, H.; Wan, Y.; Chung, A.; Cheung, C.P.; Chen, N.; et al. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization. Gastroenterology 2020, 19. [Google Scholar] [CrossRef]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Khan, A.S.; Hichami, A.; Khan, N.A. Obesity and COVID-19: Oro-Naso-Sensory Perception. J. Clin. Med. 2020, 9, 2158. https://doi.org/10.3390/jcm9072158
Khan AS, Hichami A, Khan NA. Obesity and COVID-19: Oro-Naso-Sensory Perception. Journal of Clinical Medicine. 2020; 9(7):2158. https://doi.org/10.3390/jcm9072158
Chicago/Turabian StyleKhan, Amira Sayed, Aziz Hichami, and Naim Akhtar Khan. 2020. "Obesity and COVID-19: Oro-Naso-Sensory Perception" Journal of Clinical Medicine 9, no. 7: 2158. https://doi.org/10.3390/jcm9072158